Search results
Results from the WOW.Com Content Network
Under the amendment approved by the Republican-led committee, the Department of Justice would be blocked from spending federal funds to reschedule or (de-schedule) cannabis under federal...
Cannabis, or marijuana, may be reclassified from a Schedule I to a Schedule III drug, loosening some federal restrictions. Here are five things to know.
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, a historic shift to generations of American drug policy that could have wide ripple effects across the country.
As of May 2, 2024, 38 states, the District of Columbia (DC), Puerto Rico, Guam, and the U.S. Virgin Islands have comprehensive laws and policies allowing for the medicinal use of marijuana. Nine additional states allow for “limited-access medical cannabis,” which refers to low-THC cannabis or CBD oil.
A "weed" sign advertises a cannabis dispensary in Los Angeles. With a new Trump administration coming into the White House, marijuana could remain on a path toward relaxed federal restrictions.
A new federal rule would reclassify marijuana as a less-dangerous, Schedule III drug. It’s a significant shift, even as it does not legalize the drug.
The Justice Department today announced that the Attorney General has submitted to the Federal Register a notice of proposed rulemaking initiating a formal rulemaking process to consider moving marijuana from a schedule I to schedule III drug under the Controlled Substances Act (CSA).
Senate Democrats reintroduced broad legislation on Wednesday to legalize cannabis on the federal level, a major policy shift with wide public support, but it is unlikely to be enacted this...
The Biden administration is recommending the Drug Enforcement Agency significantly lower federal restrictions on marijuana by demoting it from a Schedule 1 to a Schedule 3 drug.
WASHINGTON — The Biden administration will take a historic step toward easing federal restrictions on cannabis, with plans to announce an interim rule soon reclassifying the drug for the first...